Compare CYTK & MHK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CYTK | MHK |
|---|---|---|
| Founded | 1997 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Home Furnishings |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 6.4B |
| IPO Year | 2004 | 1992 |
| Metric | CYTK | MHK |
|---|---|---|
| Price | $68.45 | $116.02 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 11 |
| Target Price | $77.87 | ★ $139.36 |
| AVG Volume (30 Days) | ★ 1.9M | 852.2K |
| Earning Date | 11-05-2025 | 10-23-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 6.71 |
| Revenue | $87,211,000.00 | ★ $10,722,900,000.00 |
| Revenue This Year | $363.61 | $0.30 |
| Revenue Next Year | $64.33 | $2.23 |
| P/E Ratio | ★ N/A | $17.27 |
| Revenue Growth | ★ 2609.26 | N/A |
| 52 Week Low | $29.31 | $96.24 |
| 52 Week High | $69.33 | $143.13 |
| Indicator | CYTK | MHK |
|---|---|---|
| Relative Strength Index (RSI) | 62.93 | 56.45 |
| Support Level | $59.85 | $102.78 |
| Resistance Level | $67.98 | $111.21 |
| Average True Range (ATR) | 2.72 | 2.67 |
| MACD | 0.13 | 1.70 |
| Stochastic Oscillator | 91.35 | 97.93 |
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
Mohawk Industries Inc manufactures a wide range of flooring products, including carpets, rugs, ceramic tile, laminate, wood, luxury vinyl tile, and vinyl flooring. Its operating segments include Global Ceramic, Flooring North America, and Flooring Rest of the World. The company generates maximum revenue from the Global Ceramic segment. Geographically, it derives a majority of its revenue from the United States, while it also operates in Latin America, Europe and Others.